PROCEPT BioRobotics (PRCT) Revenue & Revenue Breakdown
PROCEPT BioRobotics Revenue Highlights
Latest Revenue (Y)
$224.50M
Latest Revenue (Q)
$83.33M
Main Geography (Y)
UNITED STATES
PROCEPT BioRobotics Revenue by Period
PROCEPT BioRobotics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $224.50M | 64.84% |
| 2023-12-31 | $136.19M | 81.55% |
| 2022-12-31 | $75.01M | 117.60% |
| 2021-12-31 | $34.47M | 346.72% |
| 2020-12-31 | $7.72M | 25.09% |
| 2019-12-31 | $6.17M | - |
PROCEPT BioRobotics generated $224.50M in revenue during NA 2024, up 64.84% compared to the previous quarter, and up 3639.13% compared to the same period a year ago.
PROCEPT BioRobotics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $83.33M | 5.23% |
| 2025-06-30 | $79.18M | 14.49% |
| 2025-03-31 | $69.16M | 1.36% |
| 2024-12-31 | $68.24M | 16.90% |
| 2024-09-30 | $58.37M | 9.40% |
| 2024-06-30 | $53.35M | 19.79% |
| 2024-03-31 | $44.54M | 2.20% |
| 2023-12-31 | $43.58M | 24.16% |
| 2023-09-30 | $35.10M | 6.04% |
| 2023-06-30 | $33.10M | 35.65% |
| 2023-03-31 | $24.40M | 2.64% |
| 2022-12-31 | $23.78M | 16.85% |
| 2022-09-30 | $20.35M | 21.92% |
| 2022-06-30 | $16.69M | 17.57% |
| 2022-03-31 | $14.20M | 40.04% |
| 2021-12-31 | $10.14M | 16.96% |
| 2021-09-30 | $8.67M | 2.27% |
| 2021-06-30 | $8.48M | 17.85% |
| 2021-03-31 | $7.19M | 123.28% |
| 2020-12-31 | $3.22M | 52.87% |
| 2020-09-30 | $2.11M | 76.39% |
| 2020-06-30 | $1.19M | - |
| 2020-03-31 | $1.19M | - |
PROCEPT BioRobotics generated $83.33M in revenue during Q3 2025, up 5.23% compared to the previous quarter, and up 156.18% compared to the same period a year ago.
PROCEPT BioRobotics Revenue Breakdown
PROCEPT BioRobotics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|
| UNITED STATES | $200.47M | $124.30M | $36.53M | $19.38M |
| Outside the United States | $24.03M | $11.89M | $3.20M | $2.49M |
Latest
PROCEPT BioRobotics's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (89.30%), and Outside the United States (10.70%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $73.91M | $69.58M | $60.29M | $60.39M | $52.22M | $47.67M | $40.20M | $68.37M | $32.33M | $14.83M | $8.77M | $10.45M | $9.81M | $8.52M | $7.75M | $5.01M | $5.04M |
| Outside the United States | $9.41M | $9.60M | $8.87M | $7.85M | $6.16M | $5.68M | $4.34M | $6.05M | $2.78M | $1.60M | $1.47M | $848.00K | $743.00K | $869.00K | $742.00K | $768.00K | $481.00K |
Latest
PROCEPT BioRobotics's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (88.70%), and Outside the United States (11.30%).
PROCEPT BioRobotics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| QDEL | QuidelOrtho | $2.78B | $699.90M |
| CLOV | Clover Health Investments | $1.37B | $496.65M |
| GRDN | Guardian Pharmacy Services | $1.23B | $377.43M |
| INSP | Inspire Medical Systems | $802.80M | $224.50M |
| AORT | Artivion | $388.54M | $113.39M |
| TWST | Twist Bioscience | $376.57M | - |
| PRCT | PROCEPT BioRobotics | $224.50M | $83.33M |
| BGM | BGM Group | $25.10M | $12.56M |
| SSII | SS Innovations | $20.65M | $12.83M |
| MESO | Mesoblast | $7.50M | $1.69M |
| EWTX | Edgewise Therapeutics | - | - |